Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1997 1
1998 4
1999 5
2000 2
2001 2
2002 5
2003 5
2004 3
2005 5
2006 4
2007 1
2008 1
2009 3
2010 2
2011 4
2012 4
2013 4
2014 7
2015 9
2016 6
2017 12
2018 12
2019 12
2020 10
2021 4
2022 3
Text availability
Article attribute
Article type
Publication date

Search Results

122 results
Results by year
Filters applied: . Clear all
Page 1
Berzosertib plus gemcitabine versus gemcitabine alone in platinum-resistant high-grade serous ovarian cancer: a multicentre, open-label, randomised, phase 2 trial.
Konstantinopoulos PA, Cheng SC, Wahner Hendrickson AE, Penson RT, Schumer ST, Doyle LA, Lee EK, Kohn EC, Duska LR, Crispens MA, Olawaiye AB, Winer IS, Barroilhet LM, Fu S, McHale MT, Schilder RJ, Färkkilä A, Chowdhury D, Curtis J, Quinn RS, Bowes B, D'Andrea AD, Shapiro GI, Matulonis UA. Konstantinopoulos PA, et al. Among authors: duska lr. Lancet Oncol. 2020 Jul;21(7):957-968. doi: 10.1016/S1470-2045(20)30180-7. Epub 2020 Jun 15. Lancet Oncol. 2020. PMID: 32553118 Free PMC article. Clinical Trial.
Uterine carcinosarcoma: A review of the literature.
Cantrell LA, Blank SV, Duska LR. Cantrell LA, et al. Among authors: duska lr. Gynecol Oncol. 2015 Jun;137(3):581-8. doi: 10.1016/j.ygyno.2015.03.041. Epub 2015 Mar 21. Gynecol Oncol. 2015. PMID: 25805398 Review.
Androgen Receptor Expression in Endometrial Carcinoma.
Zadeh SL, Duska LR, Mills AM. Zadeh SL, et al. Among authors: duska lr. Int J Gynecol Pathol. 2018 Mar;37(2):167-173. doi: 10.1097/PGP.0000000000000401. Int J Gynecol Pathol. 2018. PMID: 28582344
122 results